Most Recent
Court dismisses charges against former Macquarie adviser
A criminal case against a former financial adviser from Macquarie accused of trading in derivatives without a client's authority has been dismissed.
ANZ, OnePath to pay $50M in super class action settlement
Big Four bank ANZ and superannuation trustee OnePath will pay $50 million to settle a class action brought on behalf of super members allegedly charged excessive fees.
Thomson Geer snags employment team from KPMG Law
Thomson Geer has lured an employment law partner and his team from KPMG’s legal services division after the consulting firm announced it was shutting down its commercial law practice. 
Judge from Maurice Blackburn should not hear Fletcher class action, court told
A judge should be disqualified from hearing a class action against Fletcher Building because of his previous association with the funder, as well as public remarks he made as a plaintiffs' solicitor, a court has heard. 
ANZ, OnePath reach 11th-hour settlement in class action
A settlement has been reached on the eve of trial in a class action against ANZ and OnePath alleging they slugged super fund members with excessive fees.
Medibank admits lack of multi-factor authentication partly to blame for breach
Medibank has denied breaching privacy rules in response to the regulator's case over a 2022 cyber attack, but has admitted sensitive data was hacked in part because its network lacked multi-factor authentication. 
Westpac unit RAMS flags fraud claim in franchisee class action
Westpac's shuttered home loan unit RAMS may hit back at franchisees' class action claims by alleging they made misrepresentations and provided fraudulent documents.
Liquidators settle with Grant Thornton, Moore Stephens over Linchpin audits
Linchpin Capital liquidators have resolved their case against Grant Thornton and Moore Stephens, a year after a court found the evidence on its face established a claim against the auditors.
McDonald’s rest breaks class action ‘gone backwards’, court told
A class action against McDonald’s alleging workers were not given mandatory rest breaks has “gone backwards” after the fast food giant withdrew previously agreed facts, a court has heard. 
Biotech files new patent suit against Samsung Bioepis over Crohn’s drug
Samsung Bioepis can't get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug.